Custom Search

News

Monday 01 May 2006

Injectable atypical antipsychotics for agitation in borderline personality disorder.

By: Pascual JC, Madre M, Soler J, Barrachina J, Campins MJ, Alvarez E, Perez V.

Pharmacopsychiatry 2006 May;39(3):117-8

Agitation is relatively common among Borderline Personality Disorder (BPD) patients in Psychiatric Emergency Services (PES). New injectable atypical antipsychotics are indicated for treatment in agitated psychotic or maniac patients but not for agitated BDP patients. Twenty agitated BPD patients were treated with intramuscular atypical antipsychotics (olanzapine or ziprasidone). Results suggest intramuscular atypical antipsychotics may be effective, fast and safe for treating acute BPD patients.

Use of this site is subject to the following terms of use